BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 28141659)

  • 1. Altered plasma fibrin clot properties in hypertensive patients with obstructive sleep apnoea are improved by continuous positive airway pressure treatment.
    Jóźwik-Plebanek K; Prejbisz A; Wypasek E; Pręgowska-Chwała B; Hanus K; Kaszuba AM; Januszewicz M; Bieleń P; Kabat M; Kruk M; Dobrowolski P; Klisiewicz A; Śliwiński P; Januszewicz A; Undas A
    J Hypertens; 2017 May; 35(5):1035-1043. PubMed ID: 28141659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diurnal changes and levels of fibrin generation are not altered by continuous positive airway pressure (CPAP) in obstructive sleep apnoea (OSA). A randomised, placebo-controlled crossover study.
    McEwen BJ; Phillips CL; Morel-Kopp MC; Yee BJ; Sullivan DR; Ward CM; Tofler GH; Grunstein RR
    Thromb Haemost; 2012 Oct; 108(4):701-9. PubMed ID: 22918526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered plasma fibrin clot properties in essential thrombocythemia.
    Małecki R; Gacka M; Kuliszkiewicz-Janus M; Jakobsche-Policht U; Kwiatkowski J; Adamiec R; Undas A
    Platelets; 2016; 27(2):110-6. PubMed ID: 25989112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated NT-proBNP is associated with unfavorably altered plasma fibrin clot properties in atrial fibrillation.
    Matusik PT; Matusik PS; Kornacewicz-Jach Z; Małecka B; Ząbek A; Undas A
    Int J Cardiol; 2017 Sep; 243():244-250. PubMed ID: 28571619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered Plasma Clot Properties and Trauma-Related Venous Thromboembolism despite Thromboprophylaxis.
    Goldman S; Frączek P; Szklanny K; Papuga-Szela E; Stanisz A; Undas A
    Thromb Haemost; 2018 Apr; 118(4):654-663. PubMed ID: 29618152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prothrombotic fibrin clot properties associated with increased endogenous thrombin potential and soluble P-selectin predict occult cancer after unprovoked venous thromboembolism.
    Mrozinska S; Cieslik J; Broniatowska E; Malinowski KP; Undas A
    J Thromb Haemost; 2019 Nov; 17(11):1912-1922. PubMed ID: 31323706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unfavorably Altered Fibrin Clot Properties in Patients with Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Association with Thrombin Generation and Eosinophilia.
    Mastalerz L; Celińska-Lӧwenhoff M; Krawiec P; Batko B; Tłustochowicz W; Undas A
    PLoS One; 2015; 10(11):e0142167. PubMed ID: 26540111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prothrombotic clot properties can predict venous ulcers in patients following deep vein thrombosis: a cohort study.
    Polak MW; Siudut J; Plens K; Undas A
    J Thromb Thrombolysis; 2019 Nov; 48(4):603-609. PubMed ID: 31432450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered plasma fibrin clot properties in patients with digestive tract cancers: links with the increased thrombin generation.
    Gronostaj K; Richter P; Nowak W; Undas A
    Thromb Res; 2013 Mar; 131(3):262-7. PubMed ID: 23273404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prothrombotic alterations in plasma fibrin clot properties in thyroid disorders and their post-treatment modifications.
    Mazur P; Sokołowski G; Hubalewska-Dydejczyk A; Płaczkiewicz-Jankowska E; Undas A
    Thromb Res; 2014 Aug; 134(2):510-7. PubMed ID: 24962680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered plasma fibrin clot properties and fibrinolysis in patients with multiple myeloma.
    Undas A; Zubkiewicz-Usnarska L; Helbig G; Woszczyk D; Kozińska J; Dmoszyńska A; Podolak-Dawidziak M; Kuliczkowski K
    Eur J Clin Invest; 2014 Jun; 44(6):557-66. PubMed ID: 24738991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered fibrin clot properties in advanced lung cancer: strong impact of cigarette smoking.
    Ząbczyk M; Królczyk G; Czyżewicz G; Plens K; Prior S; Butenas S; Undas A
    Med Oncol; 2019 Mar; 36(4):37. PubMed ID: 30891644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced plasma fibrin clot permeability and susceptibility to fibrinolysis are associated with increased intima-media thickness in patients with primary antiphospholipid syndrome.
    Asztabski M; Wypasek E; Ząbczyk M; Undas A
    Thromb Res; 2014 Nov; 134(5):945-51. PubMed ID: 25194881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered plasma fibrin clot properties are associated with in-stent thrombosis.
    Undas A; Zalewski J; Krochin M; Siudak Z; Sadowski M; Pregowski J; Dudek D; Janion M; Witkowski A; Zmudka K
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):276-82. PubMed ID: 19910643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long term effect of autoadjusting positive airway pressure on C-reactive protein and interleukin-6 in men with obstructive sleep apnoea syndrome].
    Drummond M; Winck J; Guimarães J; Santos AC; Almeida J; Marques J
    Arch Bronconeumol; 2009 Dec; 45(12):577-84. PubMed ID: 19552994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of continuous positive airway pressure and bosentan effect in mildly hypertensive patients with obstructive sleep apnoea: A randomized controlled pilot study.
    Joyeux-Faure M; Jullian-Desayes I; Pepin JL; Cracowski JL; Baguet JP; Tamisier R; Levy P; Godin-Ribuot D; Launois SH
    Respirology; 2016 Apr; 21(3):546-52. PubMed ID: 26643404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision Medicine in Patients With Resistant Hypertension and Obstructive Sleep Apnea: Blood Pressure Response to Continuous Positive Airway Pressure Treatment.
    Sánchez-de-la-Torre M; Khalyfa A; Sánchez-de-la-Torre A; Martinez-Alonso M; Martinez-García MÁ; Barceló A; Lloberes P; Campos-Rodriguez F; Capote F; Diaz-de-Atauri MJ; Somoza M; González M; Masa JF; Gozal D; Barbé F;
    J Am Coll Cardiol; 2015 Sep; 66(9):1023-32. PubMed ID: 26314530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrin clot characteristics in acute ischaemic stroke patients treated with thrombolysis: the impact on clinical outcome.
    Bembenek JP; Niewada M; Siudut J; Plens K; Członkowska A; Undas A
    Thromb Haemost; 2017 Jun; 117(7):1440-1447. PubMed ID: 28382369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma fibrin clot properties in the G20210A prothrombin mutation carriers following venous thromboembolism: the effect of rivaroxaban.
    Janion-Sadowska A; Natorska J; Siudut J; Ząbczyk M; Stanisz A; Undas A
    Thromb Haemost; 2017 Aug; 117(9):1739-1749. PubMed ID: 28771277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired plasma clot lysis and its determinants in patients with obstructive sleep apnea syndrome.
    Borratynska A; Stopyra-Pach K; Fil K; Undas A
    Blood Coagul Fibrinolysis; 2016 Dec; 27(8):892-898. PubMed ID: 27167858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.